Efficacy and safety of a fixed dose combination of glimepiride and sustained release metformin in Indian patients with type 2 diabetes mellitus

被引：0
|
作者：
Desai, AA
Singh, KP
Rajadhyaksha, GC
Anandmoses, CR
Ballary, CC
Gawde, AS
机构：
来源：
DIABETES | 2004年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A474 / A474
页数：1
相关论文
共 50 条
  • [31] The effect of initial therapy with the fixed-dose combination of sitagliptin and metformin compared with metformin monotherapy in patients with type 2 diabetes mellitus
    Reasner, C.
    Olansky, L.
    Seck, T. L.
    Williams-Herman, D. E.
    Chen, M.
    Terranella, L.
    Johnson-Levonas, A. O.
    Kaufman, K. D.
    Goldstein, B. J.
    DIABETES OBESITY & METABOLISM, 2011, 13 (07): : 644 - 652
  • [32] Assessment of Clinical Experience of Triple Drug Fixed-dose Combination of Glimepiride, Metformin and Voglibose in the Management of Type 2 Diabetes Mellitus: A Retrospective Study
    Bantwal, Ganapathi
    Ayyar, Vageesh
    Kovil, Rajiv
    Chawla, Manoj
    Shah, Tejas
    Kumar, Sharad
    Abhyankar, Mahesh
    Revankar, Santosh
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2021, 15 (09) : OC05 - OC12
  • [33] Efficacy and safety of vildagliptin in patients with type 2 diabetes mellitus inadequately controlled with dual combination of metformin and sulphonylurea
    Lukashevich, V.
    Prato, S. D.
    Araga, M.
    Kothny, W.
    DIABETES OBESITY & METABOLISM, 2014, 16 (05): : 403 - 409
  • [34] The efficacy and safety of pioglitazone (Actos (TM)) As monotherapy and in combination with glibenclamide or metformin in patients with type 2 diabetes mellitus
    Shestakova, M. V.
    Balabolkin, M. I.
    Antsiferov, M. B.
    Mayorov, A. Y.
    Chugunova, L. A.
    Shamkhalova, M. S.
    Brevnova, N. N.
    Naumenkova, I. V.
    Zaytseva, N. V.
    Tsibina, L. V.
    Dedov, I. I.
    DIABETES MELLITUS, 2005, 8 (01): : 50 - 57
  • [35] Efficacy and safety of linagliptine in combination with metformin in patients with type 2 diabetes uncontrolled on metformin monotherapy
    Taskinen, M. -R.
    Rosenstock, J.
    Tamminen, I.
    Kubiak, R.
    Patel, S.
    Dugi, K. A.
    Tocque-le Goussee, E.
    Woerle, H. -J.
    DIABETES & METABOLISM, 2011, 37 : A107 - A108
  • [36] Empagliflozin/metformin fixed-dose combination: a review in patients with type 2 diabetes
    Hu, Jingbo
    Zou, Ping
    Zhang, Shuo
    Zhou, Minzhi
    Tan, Xueying
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (18) : 2471 - 2477
  • [37] Safety and efficacy of metformin XT to immediate-release metformin in patients with type 2 diabetes
    Niecestro, R
    Luckacsko, P
    Walters, E
    Sterman, A
    Friedhoff, L
    Isaacsohn, J
    DIABETES, 2002, 51 : A131 - A132
  • [38] Safety and efficacy of fixed-dose combination of dapagliflozin and saxagliptin in patients with type 2 diabetes mellitus - a phase 4 study in India
    Wangnoo, S. K.
    Bhadada, Sanjay Kumar
    Farishta, Faraz
    Naidu, Girithara Gopalakrishnan Jayaram
    Pattnaik, Indira
    Manohar, K. N.
    Singh, K. P.
    Gupta, Sandeep Kumar
    Bharath, H. S.
    Ghosh, Sujoy
    FRONTIERS IN ENDOCRINOLOGY, 2025, 16
  • [39] Efficacy and safety of linagliptin/metformin fixed-dose combination as initial therapy in drug-naive Asian patients with type 2 diabetes
    Gong, Y.
    Mu, Y.
    Fan, B.
    Hehnke, U.
    Pan, C.
    DIABETOLOGIA, 2015, 58 : S388 - S388
  • [40] Efficacy and safety of sitagliptin and the fixed-dose combination of sitagliptin and metformin versus pioglitazone in drug-naive patients with type 2 diabetes
    Perez-Monteverde, A.
    Seck, T.
    Xu, L.
    Liu, G.
    Lee, M. A.
    Sisk, C. McCrary
    Williams-Herman, D. E.
    Kaufman, K. D.
    Goldstein, B. J.
    DIABETOLOGIA, 2010, 53
12345